Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Will The Multiomics Market Valuation Change Between Now And 2029?

In recent times, the multiomics market has experienced a significant surge in size. The market, which is projected to evolve from a value of $3.27 billion in 2024 to $3.85 billion the following year, expects a compound annual growth rate (CAGR) of 17.7%. Factors contributing to this growth during the historic period include heightened biomedical investigations, augmented funding from both governmental and private entities, an escalation in chronic illnesses, advances in technology, and the improvement of computational tools and software designed for data analysis.

The market size of multiomics is anticipated to expand significantly in the coming years. By 2029, it is projected to reach $7.11 billion, marking a compound annual growth rate (CAGR) of 16.6%. The future growth can be credited to the development in artificial intelligence and machine learning, the expansion of clinical applications, a flourishing biopharmaceutical industry, the advent of integrated multiomics platforms, and a rising utilization in agricultural and environmental studies. There are several major trends expected during this period such as technological progress, the introduction of novel commercial multiomics platforms, the acceptance of spatially resolved multiomics investigation, implementation in biopharmaceutical research and development, and growth into clinical diagnostics.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

What Underlying Factors Are Supporting The Multiomics Market Growth?

The multiomics market is anticipated to grow due to an increase in the preference for personalized medicine. This method of healthcare is individualized, with decisions and treatments tailored to specific patient’s genetic, environmental, and lifestyle aspects. It is growing popularity is owed to advancements in technology, heightened demand for targeted therapies, and global improvements in healthcare. Multiomics contribute to personalized medicine by providing an extensive insight into a person’s genetic, molecular, and metabolic background, permitting healthcare providers to devise treatments based on the unique traits of every patient. For example, in February 2024, the FDA approved 16 new personalized therapies for patients suffering from rare diseases in 2023, as reported by the Personalized Medicine Coalition, a non-profit organization based in the US. This is a significant increase from 6 approved in 2022. Consequently, the growth of the multiomics market is driven by the increasing preference for personalized medicine.

Which Sub-Segments Are Driving Growth Within The Multiomics Market?

The multiomicsmarket covered in this report is segmented –

1) By Type: Single-Cell Multiomics; Bulk Multiomics

2) By Platform: Genomics; Transcriptomics; Proteomics; Metabolomics; Integrated Omics Platforms

3) By Application: Diagnostics; Drug Discovery And Development; Personalized Medicine; AgriGenomics; Other Applications

4) By End User: Academics And Research Organization; Pharmaceutical And Biotechnology Companies; Clinical research Organization; Other End-Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics; Single-Cell Transcriptomics; Single-Cell Epigenomics; Single-Cell Proteomics; Single-Cell Metabolomics

2) By Bulk Multiomics: Genomics; Transcriptomics; Epigenomics; Proteomics; Metabolomics

What Current And Upcoming Trends Are Shaping The Multiomics Market?

Leading firms in the multiomics sector are creating high-tech single-cell multiomics platforms, which enables scientists to conduct large-scale investigations without compromising the quality of their samples. These platforms merge different omics with artificial intelligence features, thereby facilitating users with the analysis and interpretation of intricate biological data using advanced algorithms and machine learning methods. For example, in February 2023, Becton, Dickinson, and Company, an American medical device enterprise, introduced the BD Rhapsody HT Xpress, a high-throughput single-cell multiomics platform. This state-of-the-art system gives scientists the capacity to isolate, barcode, and scrutinize single cells at high sample capability, handling up to eight times more cells compared to older versions of BD single-cell analyzers. The BD Rhapsody HT Xpress System guarantees no sample loss and provides the versatility to examine multiple samples, and various cell sizes and types simultaneously, like stem cells or cancer cells, thus improving researchers’ ability to obtain more knowledge in less time.

Which Companies Hold A Competitive Edge In The 1041 Market?

Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

Which Region Dominates The Multiomics Market Today?

North America was the largest region in the multiomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15866&type=smp

Browse Through More Reports Similar to the Global Multiomics Market 2025, By The Business Research Company

Multidrug Resistant Bacteria Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/multidrug-resistant-bacteria-global-market-report

Multi Family Housing Green Buildings Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/multi-family-housing-green-buildings-global-market-report

Multimode Fiber Cable Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/multimode-fiber-cable-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model